PAR 7.02% 26.5¢ paradigm biopharmaceuticals limited..

A huge buying opportunity, page-39

  1. 142 Posts.
    lightbulb Created with Sketch. 33
    Just to clarify the comment I made earlier today (in a rush):

    "The quality of life of approximately 7,5% (55 million) of the European population (741 million in 2016) is severely and permanently reduced by pain
    and functional impairment caused by rheumatic diseases.*

    *

    https://www.eular.org/myUploadData/files/EU_Horizon_2020_EULAR_position_paper.pdf

    Page 6 Morbidity in relation to Rheumatic and Musculoskeletal Diseases. Point 4.



 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
-0.020(7.02%)
Mkt cap ! $92.69M
Open High Low Value Volume
29.0¢ 29.0¢ 26.0¢ $229.3K 833.1K

Buyers (Bids)

No. Vol. Price($)
9 89111 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 25136 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.